definiens: '' ' ' ' --W!1E\!1Ji'''''-,Avalon Target Know - How ~ il'm!J~{tiJim.ai~~1!m ~ llleji : i8'~tsg g. II~1trlti~~J~~~and any analys~~7th;;;~i'~bt;i~;dth~- ; ~ti;;itie~-!<:I ~ o by [COMPANY] under Sections A.2 or A.3 of the Research Program;[~b$thea§ } •• J'li : t~~'t~§ UJ;;"''''U by [COMPANY] and any Know - How developed by [COMPANY] relating to the use of inhi . . of a Target in a Reference Cell or [COMPANY] Cell the Research Program ( other than [COMPANY] Core -- ', defined in ~'fjjf ~ jB'11~~iland any [COMPANY] Know - How developed by [COMPANY] under the Research Program related thereto ; and ( d ) any protein, peptide, biological agent ( including but not limited to an antibody ), Selected Compound Hit, Lead Compound, Analog of a Lead Compound, Optimized Lead LOlllr)OUma or Clinical Candidate that would have the . valent ', ', ' ! ;